UNM Health Sciences recruiting undergrads for summer 2025 research cohort
Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04)[...]
11/18/2024 | Press release | Distributed by Public on 11/17/2024 21:57
Please select the service you want to use:
Smartlinks | Intellia Therapeutics Inc. | News | Health | Science | Research | Finance | Security Markets | Security Markets | Company News | Top Company News | Corporate Debt | Business Announcement | Products and Services | Pharmaceuticals | Securities Issuers | Pharmaceutical Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact